Harm Reduction
R Street’s Harm Reduction program is grounded in an understanding that “abstinence only” approaches to risky behavior are ineffective. With this in mind, RSI focuses on harm-reduction approaches that recognize that harmful behaviors may continue to happen even as policies are enacted to help mitigate—if not eliminate—those harms. The program connects the dots between historically siloed issues such as: tobacco, cannabis, sexual health and illicit drug use.
MEDIA Contact
For general media inquiries and to book our experts, please contact [email protected].
SUPPORT US
To support this program, please contact Ginny Mansour, Director of Development, at [email protected].
Research
commentary
Outreach
Our Scholars
Mazen Saleh
Policy Director, Integrated Harm Reduction
Chelsea Boyd
Resident Research Fellow, Harm Reduction
Stacey McKenna
Resident Senior Fellow, Integrated Harm Reduction
Jessica Shortall
Safer From Harm Coalition Manager, Integrated Harm Reduction
Harm Reduction in the News
FDA should OK easier access to drug that reverses overdoses
The federal government appears to be on the verge of doing something right for a change—shocking, I know. The Food and Drug Administration (FDA) is mulling a proposal to make certain naloxone products, which reverse drug overdoses, available over-the-counter. The FDA generally doesn’t take such actions lightly—and in fact has a reputation for its long delays. Yet…